Resham Ramkissoon, MD

Introducing our final Team presenting at our upcoming #LiverRounds on May 13th!: Representing @uhhospitals we have Dr. Julie Gartland! Join us to hear the case of "Lost in Transplantation"! Register today by visiting liveralliance.org/liver-rounds/

Congrats Sahil on the poster of distinction! @cwruim @DDWMeeting

Great job, @AlekhyaMannava! @CWRUdeptMED @cwruim @DDWMeeting

@MayoClinicGIHep @PriSantiagoMD well deserved! @VictorChedidMD

We are proud to announce Dr. Chedid as the Mayo Clinic Fellows Association Teacher of the Year for Gastroenterology & Hepatology. Nominated and selected by residents and fellows, this award honors educators who demonstrate exceptional dedication to teaching, mentorship, and going above and beyond their clinical duties. Trainees describe Dr. Chedid as skilled, compassionate, thoughtful, and deeply invested in their growth. He teaches with intention, advocates for learners, and ensures every trainee feels valued—even in the busiest clinical settings. A well‑deserved recognition for an exemplary educator.

Well done, @Kelutch! @DDWMeeting @CWRU_GI @UHhospitals

🎇#BavenoVIII Best Abstracts Webinar 🗓 Tuesday May 5 | 17:00 CET 🔹 Body composition & TIPS 🔹 LSM in obese MASLD 🔹 Early TIPS & ascites (#TEAMTrial) 🔹 VCTE in PSVD 🔗Free link: t.ly/ttK4Y Meeting ID: 841 4199 8647 Passcode: B8Webinar #LiverTwitter

The flagella of Helicobacter pylori work like specialised propellers driven by a high-torque rotating motor. These convert chemical energy generated from proton gradients across the bacterial membrane into mechanical rotation. These help the bacteria to navigate the thick mucus of the human stomach to travel from highly acidic areas (pH 2) to areas with a more neutral pH (pH 5.5 to 7.5) where they thrive best. Using high-resolution electron microscopy imaging, scientists have recently characterised the architecture of this motor which form the building block of flagella, and my god, does this look like a beautiful feat of engineering. 🦠⚙️

Recompensation is reshaping how we understand cirrhosis, but key gaps remain. Join @salvatore_piano, @elizabeth_verna, and @DrLoomba in two weeks to explore how etiological control enables recompensation, what defines it clinically, and how outcomes may shift for patients. Save your seat: bit.ly/4sclXfg

Ashwagandha may not be as safe as previously thought, especially in patients with chronic liver disease. @AASLDtweets #livertwitter @CWRU_GI @NIH journals.lww.com/hepcomm/fullte…

Love this paper 1. Checking ANA in everyone with elevated ALT is unhelpful, sometimes harmful, usually confusing 2. Biopsy when ALT <100 but ANA elevated is not useful 3. Autoimmune hepatitis is a clinical diagnosis and frequently made DESPITE biopsy findings

There are no words.

Godspeed Artemis II April 1, 2026 -- 18:35 EDT

Happy #NationalDoctorsDay to all! @UHhospitals

#livertwitter @amjtransplant @UH_RE_Institute @pgholam @AASLDtweets @CWRU_GI

Are we ready for #ICI use for #HCC AFTER Liver Txp? amjtransplant.org/article/S1600-… ✅️ ~50% had progressive HCC ✅️ 1 pt had a COMPLETE response ✅️ some had a response but later progressed ✅️ 20% had rejection, 50% mortality ✅️ high risk with mTOR and PDL1 expression

Gleaming and proud today as I made a diagnosis of a #HepatitisD superinfection! Read a great review by @AnnaLok. pubmed.ncbi.nlm.nih.gov/37943548/ @CWRU_GI Disheartened to see the only @US_FDA approved treatment in the US is #PEGinterferon. #Buleviratide is approved in the EU.

Attention all patients with #LiverDisease 📢 Join @OHIOLIVER for the ABC's of #LiverTransplant patient webinar. Register using the QR code below @AASLDtweets @AmCollegeGastro @UHhospitals

Don't wait! Submit your abstract to The Liver Meeting® 2026 and ELEVATE the practice and science of liver disease. Start today >> bit.ly/4cDR53k 📆 Deadline: May 28 at 11:59 p.m. EST 📗 Regular Abstract Embargo Lift: October 5

NEW PAPER: Steroids show modest 28-day benefit in severe alcohol-associated hepatitis. @AGA_GIHN talks to corresponding author @juanpabloarab. bit.ly/4sOOYP9 #livertwitter #hepatitis

Support looks different for everyone. For some, it’s a stuffed toy. For you, it might be a colonoscopy. Colorectal cancer screening saves lives. Most people at average risk should begin screening at 45 years old. Options include colonoscopy (every 10 years if normal) or stool-based tests done at home at recommended intervals. The goal? Detect and remove precancerous polyps before they become cancer or catch cancer early, when treatment is most effective. Protect your peace. Protect your colon. Reach out if you need help getting started 💙 #CRCAwarenessMonth #Punch #Support #EnoughCRC #MayoClinicGI